GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » DuChemBio Co Ltd (XKRX:176750) » Definitions » Change In Payables And Accrued Expense

DuChemBio Co (XKRX:176750) Change In Payables And Accrued Expense : ₩0 Mil (TTM As of Dec. 2023)


View and export this data going back to 2014. Start your Free Trial

What is DuChemBio Co Change In Payables And Accrued Expense?

DuChemBio Co's Change In Payables And Accrued Expense for the quarter that ended in Dec. 2023 was ₩0 Mil. It means DuChemBio Co's Accounts Payable & Accrued Expense stayed the same from Dec. 2022 to Dec. 2023 .

DuChemBio Co's Change In Payables And Accrued Expense for the fiscal year that ended in Dec. 2023 was ₩0 Mil. It means DuChemBio Co's Accounts Payable & Accrued Expense stayed the same from Dec. 2022 to Dec. 2023 .

DuChemBio Co Change In Payables And Accrued Expense Historical Data

The historical data trend for DuChemBio Co's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DuChemBio Co Change In Payables And Accrued Expense Chart

DuChemBio Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Change In Payables And Accrued Expense
Get a 7-Day Free Trial - - - - -

DuChemBio Co Semi-Annual Data
Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Change In Payables And Accrued Expense Get a 7-Day Free Trial - - - - -

DuChemBio Co Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Dec. 2023 was ₩0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

DuChemBio Co Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of DuChemBio Co's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

DuChemBio Co (XKRX:176750) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » DuChemBio Co Ltd (XKRX:176750) » Definitions » Change In Payables And Accrued Expense
Comparable Companies
XKRX:002620 XKRX:214390 XKRX:023910 XKRX:082800 XKRX:002390 XKRX:061250 XKRX:006620 XKRX:003120 XKRX:002210 XKRX:293780 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
N/A
Address
Daegu 47, Jinyang Building, 4th floor, Chungjeong-ro 2, Gyeonggi, Seoul, KOR, 190-3
Website
http://www.duchembio.com
DuChemBio Co Ltd is engaged in manufacturing and sale of radiopharmaceuticals and radioactive medicines. It also imports and sells medical equipment related to nuclear medicines.

DuChemBio Co (XKRX:176750) Headlines

No Headlines